The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Efficacy of the hypomethylating agents as frontline, salvage, or maintenance therapy among older adults with acute myeloid leukemia (AML).
Bernard Tawfik
No relevant relationships to disclose
Sarunas Sliesoraitis
No relevant relationships to disclose
Heidi D. Klepin
No relevant relationships to disclose
Julia Lawrence
No relevant relationships to disclose
Scott Isom
No relevant relationships to disclose
Leslie R. Ellis
No relevant relationships to disclose
Susan Lyerly
No relevant relationships to disclose
Megan Manuel
No relevant relationships to disclose
Sarah Dralle
No relevant relationships to disclose
Dmitriy P. Berenzon
No relevant relationships to disclose
Bayard L. Powell
No relevant relationships to disclose
Timothy S. Pardee
No relevant relationships to disclose